• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106015
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage, Cerebral (1889); Blood Loss (2597)
Event Date 04/15/2019
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the reported subdural hematoma, as well as a direct correlation to heartmate ii left ventricular assist device (lvas), serial number (b)(4), could not be conclusively determined through this evaluation.The patient remains ongoing on (b)(4) with no further related issues at this time.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate ii lvas instructions for use (ifu) lists stroke, neurologic dysfunction, and bleeding as adverse events that may be associated with the use of the heartmate ii left ventricular assist system.This ifu also outlines the recommended anticoagulation therapy and inr range.No further information was provided.The manufacturer is closing the file on this event.
 
Event Description
It was reported that the patient had acute worsening of weakness in their left arm and was relying on their walker to get around.The patient saw their primary care physician (pcp) the next day, who ordered a computed tomography (ct) scan of the patient's head on (b)(6) 2019.That ct scan revealed a right subdural hematoma and the patient was admitted to duke hospital.Originally, the patient presented with fatigue, malaise, and lower extremity weakness from (b)(6) 2020.At that time it was felt that his non specific symptoms were likely related to deconditioning and possible contribution from his interferon therapy.On admission, the patient was hemodynamically stable and conversant.In the emergency room (er) he received a repeat ct of his brain which revealed mixed age (subacute) subdural hemorrhage with midline shift.Neurosurgery was consulted and the patient underwent a right-sided craniotomy with evacuation.The patient's left-sided weakness continued to improve and anticoagulation was restarted 3 days post-op following neurosurgery approval and repeat ct scan.The midline shift remained stable on ct with therapeutic anticoagulation.Warfarin was also restarted for goal international normalized ratio (inr) 1.5-2.The patient was treated with 7 days of keppra for seizure prophylaxis and blood pressure was maintained at goal mean arterial pressure (map) <90 by starting carvedilol.The patient did not tolerate lisinopril due to dizziness.The patient developed left arm weakness later in admission; a repeat ct was unchanged and weakness improved rapidly.Neurology signed off.Physical therapy was consulted and the patient was able to ambulate and was discharged home with pt/ot and tolling walker.The patient's left-sided weakness was much improved by discharge on (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key10949006
MDR Text Key220984912
Report Number2916596-2020-05782
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public00813024011224
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/30/2018
Device Model Number106015
Device Catalogue Number106015
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/16/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/13/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age77 YR
Patient Weight90
-
-